Patents
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
09/2004
09/16/2004WO2004078733A1 Quinazolines useful as modulators of ion channels
09/16/2004WO2004078732A1 N-aryl heteroaromatic products, compositions containing same and use thereof
09/16/2004WO2004078731A1 Quinoline-carboxylic acids and the derivatives thereof, a focused library
09/16/2004WO2004078729A1 Process for the production of substituted nicotinic acid esters
09/16/2004WO2004078128A2 Substituted pyridine derivatives useful in the treatment of cancer and other disorders
09/16/2004WO2004062562A3 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
09/16/2004WO2004048544A3 Ca ix-specific inhibitors
09/16/2004WO2004047837A3 Beta-blockers having antioxidant and nitric oxide-donor activity
09/16/2004WO2004047730A3 Compounds for inhibition of hiv infection by blocking hiv entry
09/16/2004WO2004046101A3 Cyanoguanidines and cyanoamidines as erbb2 and egfr inhibitors
09/16/2004WO2004033652A3 Inhibitors of fatty acid amide hydrolase
09/16/2004WO2003104257A3 Protease inhibitors
09/16/2004WO2003072553A8 N-aryl-2-oxazolidinone-5-carboxamides and their derivates and their use as antibacterials
09/16/2004WO2003028729A3 Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade
09/16/2004US20040181067 Tri(cyclo) substituted amide compounds
09/16/2004US20040181066 Tyrosine kinase inhibitors
09/16/2004US20040181062 Benzimidazole cyclooxygenase-2 inhibitor
09/16/2004US20040181059 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents
09/16/2004US20040180942 modulating farnesoid X receptor (FXR), liver X receptors (LXR alpha and LXR beta ) and/or orphan nuclear receptors; treatment of lipid, cardiovascular and neurodegenerative disorders
09/16/2004US20040180936 having an inhibitory activity on calpains and/or a trapping activity on reactive oxygen species; inflammatory and immunological diseases; disorders of the central or peripheral nervous system
09/16/2004US20040180925 such as (S)-1-[2-(2-Pyrazinylamino)ethylamino]acetyl-2-pyrrolidinecarbonitrile dimethanesulfonate
09/16/2004US20040180924 Novel heterocyclic derivatives and medicinal use thereof
09/16/2004US20040180912 for promoting the release of parathyroid hormone, e.g. for preventing or treating bone conditions which are associated with increased calcium depletion or resorption or in which stimulation of bone formation and calcium fixation in the bone is desirable
09/16/2004US20040180906 Anti-inflammatory medicaments
09/16/2004US20040180902 3-Substituted quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
09/16/2004US20040180887 N-aroyl cyclic amine derivatives as orexin receptor antagonists
09/16/2004US20040180885 Indole derivatives, process for preparation of the same and use thereof
09/16/2004US20040180878 Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use
09/16/2004US20040180877 Nicotinic acetylcholine receptor cholinergic ligands, monoamine receptor and transporter modulators; such as 1-(2-Benzo[b]thiophenyl-1,1-dioxide)-imidazolidine
09/16/2004CA2517844A1 Quinazolines useful as modulators of ion channels
09/16/2004CA2517708A1 5-phenylthiazole derivatives and their use as p13 kinase inhibitors
09/16/2004CA2517422A1 Tetrahydropyran compounds as tachykinin antagonists
09/16/2004CA2517088A1 Biaryltetrahydroisoquinoline piperidines as selective mch receptor antagonists for the treatment of obesity and related disorders
09/16/2004CA2516931A1 Novel bicyclic urea derivatives useful in the treatment of cancer and other disorders
09/16/2004CA2512243A1 N-aryl heteroaromatic products, compositions containing same and use thereof
09/15/2004EP1457490A1 5-membered N-heterocyclic compounds with hypoglycemic and hypolipidemic activity
09/15/2004EP1457488A1 Intermediates for use in the preparation of urea compounds having muscarinic receptor antagonist activity
09/15/2004EP1456207A2 Heterocyclic acridone inhibitors of impdh enzyme
09/15/2004EP1456203A1 Ethylene diamine derivatives and their use as orexin-receptor antagonists
09/15/2004EP1456202A1 Benzothiazoles
09/15/2004EP1456188A1 7-amino-benzothiazole derivatives as adenosine receptor ligands
09/15/2004EP1456187A1 N-substituted heterocycles for the treatment of hypercholesteremia, dyslipidemia and other metabolic disorders, cancer, and other diseases
09/15/2004EP1456180A1 3,4-diarylpyrazoles and their use in the therapy of cancer
09/15/2004EP1456172A1 Pyrrolidine-2-ones as factor xa inhibitors
09/15/2004EP1455792A1 Ureas of 2-aminobenzothiazoles as adenosine modulators
09/15/2004EP1455785A1 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same
09/15/2004EP1455777A1 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders
09/15/2004EP1455579A1 Pyrazoles-pyrimidine fungicides
09/15/2004EP1363902B1 Chemical compounds
09/15/2004EP1349849B1 Microbiocidal n-phenyl-n-[4-(4-pyridyl)-2-pyrimidin-2-yl]-amine derivatives
09/15/2004EP1295878B1 Pyrazinone derivatives
09/15/2004EP1254135B1 Aminoheterocyclylamides as pesticides and antiparasitic agents
09/15/2004EP1196408B1 Respiratory syncytial virus replication inhibitors
09/15/2004EP1185526B1 Novel quaternary ammonium derivatives, method for preparing same and pharmaceutical use
09/15/2004EP1169311A4 Oxazole and thiazole combinatorial libraries
09/15/2004EP0983054B1 Hair growth compositions and uses
09/15/2004CN1529698A Taiazole or oxazole derivatives which are useful in treatment of cardiovascular and related diseases
09/15/2004CN1529601A 四氢喹啉衍生物 Tetrahydroquinoline derivative
09/15/2004CN1529596A Utilization of benzdihydro-pyrane
09/15/2004CN1528761A N-tert-butyl-2 (benzothiazyl) sulfenamide and production process thereof
09/15/2004CN1166665C Arylpiperidine derivatives and use thereof
09/15/2004CN1166629C Benzene sulfonamide compounds, its preparing method and medicinal compsns. contg. same
09/14/2004US6790957 Converting tertiary hydroxy group of a triazole antifungal compound into a phosphate group to improve aqueous solubility
09/14/2004US6790864 Nonsteroidal antiinflammatory drugs which have been substituted with a nitrogen monoxide group; compositions comprising (i) a nonsteroidal antiinflammatory drug, which can optionally be substituted with a nitrogen monoxide group
09/14/2004US6790860 Pyrrolidine derivatives
09/14/2004US6790859 Therapy or reducing progression of hypertension or damage to a tissue caused by contact with elevated levels of reducing sugars in an animal, comprising administering to the animal an effective amount of thiazolium compounds
09/14/2004US6790844 Muscle relaxants; antiserotonine agent
09/10/2004WO2004076693A1 Tailored treatment suitable for different forms of mastocytosis
09/10/2004WO2004076447A1 Cycloalkyl derivatives comprising bioisosteric carboxylic acid groups, method for the production thereof, and use thereof as a medicament
09/10/2004WO2004076441A1 Process for producing acid adduct salt of polyacidic base compound
09/10/2004WO2004076424A1 Heterocyclic kinase inhibitors
09/10/2004WO2004076421A1 Heterocyclic amides, method for the production thereof, substances containing said heterocyclic amides, and use thereof as pesticides
09/10/2004WO2004076420A1 Heteroarylcarbamoylbenzene derivative
09/10/2004WO2004076415A1 1- (hetero)aroyl-pyrrolidine-2-carboxylic acid derivatives useful as anti.viral agents
09/10/2004WO2004076413A2 Phenyl- and pyridylpiperidine-derivatives as modulators of glucose metabolism
09/10/2004WO2004076412A2 Aminoheteroaryl compounds as protein kinase inhibitors
09/10/2004WO2004075895A1 Ocular hypotensive agent
09/10/2004WO2004060362A3 COMPOSITIONS AND METHODS FOR INHIBITING TGF-β
09/10/2004WO2004056832A3 Epothilone derivatives
09/10/2004WO2004047769A3 Benzimidazoles and analogs thereof as antibacterials
09/10/2004WO2004041776A3 SULFONYLAMINOVALEROLAC TAMS AND DERIVATIVES THEREOF AS FACTOR Xa INHIBITORS
09/10/2004WO2003087092A3 Inhibitors of serine proteases, particularly hepatitis c virus ns3 - ns4 protease
09/10/2004CA2517308A1 Tailored treatment suitable for different forms of mastocytosis
09/10/2004CA2517256A1 Aminoheteroaryl compounds as protein kinase inhibitors
09/10/2004CA2516657A1 Cycloalkyl derivatives comprising bioisosteric carboxylic acid groups, method for the production thereof, and use thereof as a medicament
09/10/2004CA2516407A1 Heteroarylcarbamoylbenzene derivatives
09/10/2004CA2515963A1 Phenyl- and pyridylpiperidine-derivatives as modulators of glucose metabolism
09/09/2004US20040176609 Compounds used as bactericides for treatment of infections
09/09/2004US20040176605 Compounds as antumor agents or immunosuppressants
09/09/2004US20040176603 Substituted nitrogen-containing heterobicycles, the preparation thereof and their use as pharmaceutical compositions
09/09/2004US20040176594 Drugs that inhibit phosphorylation kinases as an antigrowth or antiproliferation agent
09/09/2004US20040176593 Cyclic diamine compounds used as drugs and chemical intermediates
09/09/2004US20040176443 Capsaicin receptor ligands
09/09/2004US20040176433 treatment of tumor necrosis factor mediated disorders; asthma; inflammatory bowel disease; arthritis
09/09/2004US20040176432 simplified manner using considerably less process steps and with considerably improved yield and diastereoselectivity
09/09/2004US20040176431 Antiproliferative 2-(sulfo-phenyl)-aminothiazole derivatives and pharmaceutical compositions, and methods for their use
09/09/2004US20040176428 treatment of Type 2 diabetes mellitus, obesity and lipid disorders; coadministration with HMG CoA reductase inhibitors
09/09/2004US20040176427 Alpha type human peroxisome proliferator activated receptor agonists; such as 2-methyl-2-(3-methyl-4-(((4-phenoxymethyl-2-(4-trifluoromethylphenyl) -thiazol-5-yl-carbonyl)-amino)-methyl)phenoxy)propionic acid
09/09/2004US20040176422 Heteroarylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase
09/09/2004US20040176418 protease activated receptor (PAR) antagonists will be useful in the treatment of thrombotic, inflammatory, atherosclerotic and fibroproliferative disorders